RPL29

Across TCGA pan-cancer cohorts, RPL29 mass-spec protein is linked to patient survival in 8 of 34 cancer types, making it a survival-associated RPL29 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RPL29 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL29 expression acts as an unfavorable survival marker, although some lineages such as COAD and HNSC show a favorable association.

COAD, GBM, and HNSC are the cancer types where RPL29 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	1.000	0.898	.039	18	view →
GBM	OS	Median	All	0.405	0.660	.003	6	view →
HNSC	DFS	Tertile	III,IV	1.000	0.382	.027	6	view →
LUAD	DFS	Median	II,III,IV	0.274	0.687	.032	5	view →
UCEC	DFS	Quartile	II,III,IV	0.871	0.352	.040	4	view →
PDAC	OS	Tertile	II,III,IV	0.258	0.576	.006	4	view →
CCRCC	OS	Median	III,IV	0.595	0.778	.049	1	view →
LSCC	DFS	Quartile	All	0.647	0.901	.046	1	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RPL29–COAD (DFS)

Open the COAD breakdown →